AR240834A1 - Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina - Google Patents

Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina

Info

Publication number
AR240834A1
AR240834A1 AR297667A AR29766784A AR240834A1 AR 240834 A1 AR240834 A1 AR 240834A1 AR 297667 A AR297667 A AR 297667A AR 29766784 A AR29766784 A AR 29766784A AR 240834 A1 AR240834 A1 AR 240834A1
Authority
AR
Argentina
Prior art keywords
oxyphosphoryl
cholestanyl
3beta
preparing
procedure
Prior art date
Application number
AR297667A
Other languages
English (en)
Other versions
AR240834A2 (es
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR240834A2 publication Critical patent/AR240834A2/es
Publication of AR240834A1 publication Critical patent/AR240834A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR297667A 1983-08-25 1984-08-22 Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina AR240834A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (2)

Publication Number Publication Date
AR240834A2 AR240834A2 (es) 1991-02-28
AR240834A1 true AR240834A1 (es) 1991-02-28

Family

ID=4279973

Family Applications (1)

Application Number Title Priority Date Filing Date
AR297667A AR240834A1 (es) 1983-08-25 1984-08-22 Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina

Country Status (21)

Country Link
US (1) US4680290A (es)
EP (1) EP0135762B1 (es)
JP (1) JPS6061595A (es)
KR (1) KR850001767A (es)
AR (1) AR240834A1 (es)
AT (1) ATE37883T1 (es)
AU (1) AU574706B2 (es)
CA (1) CA1252778A (es)
DE (1) DE3474552D1 (es)
DK (1) DK347584A (es)
ES (2) ES535391A0 (es)
FI (1) FI842830A (es)
GR (1) GR80196B (es)
HU (1) HU189929B (es)
IL (1) IL72725A (es)
MC (1) MC1618A1 (es)
NO (1) NO161679C (es)
NZ (1) NZ209275A (es)
PH (1) PH19849A (es)
PT (1) PT79130B (es)
ZA (1) ZA846430B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (en) * 1985-05-31 1988-09-13 Pierre R. Proulx Conjugated polyene sterol derivatives as membrane probes
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
CA2028759A1 (en) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroids
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
EP0796112A4 (en) * 1994-11-30 1999-12-01 Amur Research Corp MEDICINAL DERIVATIVES OF PHOSPHOCHOLIN
JPH11507815A (ja) * 1995-06-07 1999-07-13 ジンタ・インコーポレイテッド ホスホン酸基本カチオン性脂質
WO1996040726A1 (en) * 1995-06-07 1996-12-19 Genta Incorporated Novel carbamate-based cationic lipids
JP2002514183A (ja) * 1996-09-17 2002-05-14 スーパージェン・インコーポレーテッド リン脂質薬剤誘導体
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
CN1396908A (zh) 2000-01-28 2003-02-12 宝洁公司 美味的精氨酸化合物及其用于心血管健康的应用
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
EP2097081A1 (en) * 2006-12-08 2009-09-09 Jado Technologies GmbH Cholesterylamines for the treatment and prevention of infectious diseases
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
WO2023122075A1 (en) * 2021-12-20 2023-06-29 Ohio State Innovation Foundation Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
AU574706B2 (en) 1988-07-14
ATE37883T1 (de) 1988-10-15
PT79130A (en) 1984-09-01
MC1618A1 (fr) 1985-07-18
NO161679B (no) 1989-06-05
US4680290A (en) 1987-07-14
CA1252778A (en) 1989-04-18
GR80196B (en) 1985-01-02
FI842830A (fi) 1985-02-26
PH19849A (en) 1986-07-22
PT79130B (en) 1986-11-14
HUT34997A (en) 1985-05-28
ZA846430B (en) 1985-04-24
FI842830A0 (fi) 1984-07-13
DE3474552D1 (en) 1988-11-17
HU189929B (en) 1986-08-28
DK347584A (da) 1985-02-26
ES8602844A1 (es) 1985-12-01
ES543646A0 (es) 1986-05-01
EP0135762B1 (de) 1988-10-12
JPS6061595A (ja) 1985-04-09
DK347584D0 (da) 1984-07-13
ES8606879A1 (es) 1986-05-01
KR850001767A (ko) 1985-04-01
IL72725A0 (en) 1984-11-30
AU3222584A (en) 1985-02-28
NZ209275A (en) 1987-06-30
AR240834A2 (es) 1991-02-28
EP0135762A2 (de) 1985-04-03
EP0135762A3 (en) 1986-01-22
NO161679C (no) 1989-09-13
IL72725A (en) 1988-07-31
NO843406L (no) 1985-02-26
ES535391A0 (es) 1985-12-01

Similar Documents

Publication Publication Date Title
ES529282A0 (es) Procedimiento para preparar derivados de tiazol
ES534787A0 (es) Procedimiento para preparar etinglicoles
ES526827A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
ES536138A0 (es) Procedimiento para preparar derivados azolicos
AR240834A1 (es) Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina
ES537992A0 (es) Procedimiento para preparar 2-fenil-imidazoles
ES533995A0 (es) Procedimiento para preparar imidasoles
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
MX161088A (es) Procedimiento para preparar derivados de 1-metil-5-p-tolilpirrol-2-acetamida
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
ES539312A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
ES534227A0 (es) Procedimiento para preparar piridinas
MX157788A (es) Procedimiento para preparar derivados de oxima
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES524830A0 (es) Procedimiento para preparar derivados de xantina
ES527164A0 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
ES521847A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES530037A0 (es) Procedimiento para preparar imidazolamidas
ES525943A0 (es) Procedimiento para producir derivados de tiatriazina
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
ES533024A0 (es) Procedimiento para preparar meta-o para-isopropenil-alfa-alfa-dimetilbencilamina
ES530573A0 (es) Procedimiento para preparar derivados de pirazol-1,5-a-piridina
ES528807A0 (es) Procedimiento para preparar compuestos de ftalocianina